MUMBAI, India, Jan. 2 -- Intellectual Property India has published a patent application (202511102200 A) filed by University Of Delhi, New Delhi, on Oct. 23, 2025, for 'cannabidiol-loaded mesenchymal stem cell-derived exosome composition and process for its preparation.'
Inventor(s) include Dr. Shashank Kumar Maurya; Dr. Sanjay Kumar Dey; Anurag Thapliyal; Diksha Rani; and Vaibhav Kushwaha.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The disclosure provides a cannabidiol-loaded mesenchymal stem cell exosome composition and a process for its preparation. The composition comprises exosomes derived from bone-marrow mesenchymal stem cells having cannabidiol molecularly incorporated therein, wherein the cannabidiol is dissolved in an absolute ethanolic system that enables both exosomal incorporation and analytical quantification. The formulation further contains sucrose and bovine serum albumin as stabilizing excipients to maintain vesicle morphology and prevent aggregation. The process includes isolating exosomes from conditioned medium of bone-marrow mesenchymal stem cells, preparing an ethanolic cannabidiol solution, combining the solution with exosomes under controlled incubation or sonication, and purifying the formulation by ultrafiltration to remove un-entrapped cannabidiol. The resulting composition constitutes a stable, nanoscale, and analytically compatible exosomal dispersion suitable for reproducible cannabinoid encapsulation and extendable to other hydrophobic bioactive compounds."
Disclaimer: Curated by HT Syndication.
